{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T13:29:30Z","timestamp":1788960570619,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Saudi Dental Journal"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.sdentj.2023.07.006","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T16:46:10Z","timestamp":1688661970000},"page":"785-796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Correlation of anti-TNF-a biological therapy with periodontal conditions and osteonecrosis in autoimmune patients: A systematic review"],"prefix":"10.1007","volume":"35","author":[{"given":"Rana","family":"Majdi Abunemer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakan","family":"Saifuddin Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renad","family":"Abudullah Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.sdentj.2023.07.006_b0005","unstructured":"Abreu MT. Anti-TNF Failures in Crohn\u2019s Disease. :3."},{"issue":"1","key":"10.1016\/j.sdentj.2023.07.006_b0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.joms.2016.07.019","article-title":"Osteonecrosis of the jaw in the absence of antiresorptive or antiangiogenic exposure: A series of 6 cases","volume":"75","author":"Aghaloo","year":"2017","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"11","key":"10.1016\/j.sdentj.2023.07.006_b0015","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.3390\/app11114865","article-title":"Management of patients under treatment with monoclonal antibodies and new biological therapies","volume":"11","author":"Amigo-Basilio","year":"2021","journal-title":"Appl. Sci."},{"key":"10.1016\/j.sdentj.2023.07.006_b0020","unstructured":"Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF Antagonists Inhibit the Inflammatory Response and Bone Loss in Experimental Periodontitis. :8."},{"issue":"3","key":"10.1016\/j.sdentj.2023.07.006_b0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijom.2019.08.007","article-title":"Osteonecrosis of the jaw in patients with inflammatory bowel disease treated with tumour necrosis factor alpha inhibitors","volume":"49","author":"Brijs","year":"2020","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.sdentj.2023.07.006_b0030","first-page":"1","article-title":"Adalimumab: Another medication related to osteonecrosis of the jaws?","volume":"2016","author":"Cassoni","year":"2016","journal-title":"Case Rep. Dent."},{"issue":"6","key":"10.1016\/j.sdentj.2023.07.006_b0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bjoms.2006.06.004","article-title":"Treatment with infliximab: Implications in oral surgery?","volume":"45","author":"Ciantar","year":"2007","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"6","key":"10.1016\/j.sdentj.2023.07.006_b0040","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.joms.2019.01.033","article-title":"Adalimumab-related dental implant infection","volume":"77","author":"Cillo","year":"2019","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"18","key":"10.1016\/j.sdentj.2023.07.006_b0045","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.3390\/ijms20184541","article-title":"Linkage of periodontitis and rheumatoid arthritis: current evidence and potential biological interactions","volume":"20","author":"de Molon","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.sdentj.2023.07.006_b0050","series-title":"Handbook of Therapeutic Antibodies","author":"D\u00fcbel","year":"2007"},{"key":"10.1016\/j.sdentj.2023.07.006_b0055","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.12659\/AJCR.905355","article-title":"A case of osteonecrosis of the jaw in a patient with crohn\u2019s disease treated with infliximab","volume":"18","author":"Favia","year":"2017","journal-title":"Am. J. Case Rep."},{"key":"10.1016\/j.sdentj.2023.07.006_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2020.104680","article-title":"Influence of infliximab therapy on bone healing post-dental extraction in rats","volume":"112","author":"Ferreira-Junior","year":"2020","journal-title":"Arch. Oral Biol."},{"issue":"1","key":"10.1016\/j.sdentj.2023.07.006_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14737167.2016.1140576","article-title":"Older anti-TNF-\u03b1 agents: why not group them for common indications in the EU?","volume":"16","author":"Garattini","year":"2016","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"10.1016\/j.sdentj.2023.07.006_b0070","unstructured":"Gerriets V, Goyal A, Khaddour K. Tumor Necrosis Factor Inhibitors. In: StatPearls [Internet]. Treasure Island (FL); 2022:1-10. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482425\/?report=reader."},{"issue":"8","key":"10.1016\/j.sdentj.2023.07.006_b0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.bdj.2014.905","article-title":"Drugs, medications and periodontal disease","volume":"217","author":"Heasman","year":"2014","journal-title":"Br. Dent. J."},{"key":"10.1016\/j.sdentj.2023.07.006_b0080","unstructured":"Kadkhoda Z, Amirzargar A, Esmaili Z, Vojdanian M, Akbari S. Effect of TNF-\u03b1 Blockade in Gingival Crevicular Fluid on Periodontal Condition of Patients with Rheumatoid Arthritis. Published online 2016:7."},{"issue":"6","key":"10.1016\/j.sdentj.2023.07.006_b0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ccr3.112","article-title":"Oral infection control to assist infliximab therapy in a Beh\u00e7et\u2019s disease patient with severe eye inflammation in response to dental treatment: a case report","volume":"2","author":"Kudo","year":"2014","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.sdentj.2023.07.006_b0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-051X.2009.01415.x","article-title":"Gingivitis as a risk factor in periodontal disease","volume":"36","author":"Lang","year":"2009","journal-title":"J. Clin. Periodontol."},{"issue":"9","key":"10.1016\/j.sdentj.2023.07.006_b0095","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/ecco-jcc\/jjv096","article-title":"Infliximab-related infusion reactions: Systematic review","volume":"9","author":"Lichtenstein","year":"2015","journal-title":"ECCOJC"},{"issue":"12","key":"10.1016\/j.sdentj.2023.07.006_b0100","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/ph14121209","article-title":"The effect of acknowledged and novel anti-rheumatic therapies on periodontal tissues\u2014A narrative review","volume":"14","author":"Martu","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.sdentj.2023.07.006_b0105","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1902\/jop.2009.090015","article-title":"Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis","volume":"80","author":"Mayer","year":"2009","journal-title":"J. Periodontol."},{"issue":"9","key":"10.1016\/j.sdentj.2023.07.006_b0110","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2217\/imt.13.94","article-title":"Current immunotherapy in rheumatoid arthritis","volume":"5","author":"Meier","year":"2013","journal-title":"Immunotherapy"},{"issue":"23","key":"10.1016\/j.sdentj.2023.07.006_b0115","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1915315","article-title":"Rituximab for high-risk, mature B-cell non-hodgkin\u2019s lymphoma in children","volume":"382","author":"Minard-Colin","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.sdentj.2023.07.006_b0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int. Immunol."},{"issue":"17\u201318","key":"10.1016\/j.sdentj.2023.07.006_b0125","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00508-006-0670-6","article-title":"Biological therapies: concepts and challenges","volume":"118","author":"M\u00fcller","year":"2006","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.sdentj.2023.07.006_b0130","unstructured":"Mu\u00f1oz-Mart\u00ednez C, Segura-Puertas M, G\u00f3mez-Moreno G. Disease-Modifying Antirheumatic Drugs (DMARDs) and drug interactions in dentistry. :9."},{"key":"10.1016\/j.sdentj.2023.07.006_b0135","first-page":"5","article-title":"Classical and paradoxical effects of TNF-\u03b1 on bone homeostasis","author":"Osta","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.sdentj.2023.07.006_b0140","unstructured":"Pan A, Gerriets V. Etanercept. StatPearls. Published online May 19, 2022. Accessed June 15, 2022. https:\/\/www.statpearls.com\/ArticleLibrary\/viewarticle\/21381."},{"issue":"9","key":"10.1016\/j.sdentj.2023.07.006_b0145","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1902\/jop.2008.070616","article-title":"Anti\u2013TNF-\u03b1 immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis","volume":"79","author":"Pers","year":"2008","journal-title":"J. Periodontol."},{"issue":"1","key":"10.1016\/j.sdentj.2023.07.006_b0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-230X-14-6","article-title":"Osteonecrosis of the jaw in a Crohn\u2019s disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report","volume":"14","author":"Preidl","year":"2014","journal-title":"BMC Gastroenterol."},{"issue":"4","key":"10.1016\/j.sdentj.2023.07.006_b0155","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.rdc.2006.07.004","article-title":"Inflammation-induced bone loss: Can it be prevented?","volume":"32","author":"Romas","year":"2006","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.sdentj.2023.07.006_b0160","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.oooo.2020.12.001","article-title":"Is medication-related osteonecrosis of the jaw associated with tumor necrosis factor-\u03b1 inhibition?","volume":"131","author":"Rosenberg","year":"2021","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"issue":"1","key":"10.1016\/j.sdentj.2023.07.006_b0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1741-7015-11-88","article-title":"Biologic therapy for autoimmune diseases: an update","volume":"11","author":"Rosman","year":"2013","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.sdentj.2023.07.006_b0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bjoms.2019.09.023","article-title":"Osteonecrosis and osteomyelitis of the jaw associated with tumour necrosis factor-alpha (TNF-\u03b1) inhibitors: a systematic review","volume":"58","author":"Sacco","year":"2020","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.sdentj.2023.07.006_b0175","doi-asserted-by":"crossref","unstructured":"Department of Oral, Maxillofacial and Facial Plastic Surgery, Klinikum Ludwigshafen (Hospital), Ludwigshafen, Germany, Sakkas A. Osteonecrosis of the Jaw in a Crohn\u2019s Disease Patient following Infliximab Therapy: A Case Report and Literature Review. J Adv Plast Surg Res. 2020;6(1):14-21. doi:10.31907\/2414-2093.2020.06.04.","DOI":"10.31907\/2414-2093.2020.06.04"},{"key":"10.1016\/j.sdentj.2023.07.006_b0180","doi-asserted-by":"crossref","unstructured":"Sakunrangsit N, Metheepakornchai P, Kumpunya S, et al. Etanercept prevents TNF-\u03b1 mediated mandibular bone loss in Fc\u03b3RIIb-\/- lupus model. Stein G, ed. PLoS ONE. 2021;16(4):e0250215. doi:10.1371\/journal.pone.0250215.","DOI":"10.1371\/journal.pone.0250215"},{"issue":"5","key":"10.1016\/j.sdentj.2023.07.006_b0185","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn\u2019s disease: A randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.sdentj.2023.07.006_b0190","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4161\/mabs.29105","article-title":"Rituximab: How approval history is reflected by a corresponding patent filing strategy","volume":"6","author":"Storz","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.sdentj.2023.07.006_b0195","doi-asserted-by":"crossref","unstructured":"Thimbleby H. Technology and the Future of Healthcare. Journal of Public Health Research. 2013;2(3):jphr.2013.e28. doi:10.4081\/jphr.2013.e28.","DOI":"10.4081\/jphr.2013.e28"},{"issue":"5","key":"10.1016\/j.sdentj.2023.07.006_b0200","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajoms.2016.03.003","article-title":"Mandibular osteomyelitis implicated in infliximab and periapical periodontitis: A case report","volume":"28","author":"Tsuchiya","year":"2016","journal-title":"J. Oral Maxillofac. Surg. Med. Pathol."},{"issue":"5","key":"10.1016\/j.sdentj.2023.07.006_b0205","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10753-013-9652-9","article-title":"Host modulation in rheumatoid arthritis patients with TNF blockers significantly decreases biochemical parameters in periodontitis","volume":"36","author":"\u00dcst\u00fcn","year":"2013","journal-title":"Inflammation"},{"issue":"7","key":"10.1016\/j.sdentj.2023.07.006_b0210","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn\u2019s disease","volume":"124","author":"Van den Brande","year":"2003","journal-title":"Gastroenterology"},{"issue":"37","key":"10.1016\/j.sdentj.2023.07.006_b0215","doi-asserted-by":"crossref","first-page":"26287","DOI":"10.1074\/jbc.274.37.26287","article-title":"Transmembrane tumor necrosis factor (TNF)-\u03b1 inhibits adipocyte differentiation by selectively activating TNF receptor 1","volume":"274","author":"Xu","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.sdentj.2023.07.006_b0220","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3389\/fimmu.2018.00784","article-title":"Role of TNF\u2013TNF receptor 2 signal in regulatory T cells and its therapeutic implications","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.sdentj.2023.07.006_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591365","article-title":"Use of TNF inhibitors in rheumatoid arthritis and implications for the periodontal status: For the benefit of both?","volume":"11","author":"Zamri","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.sdentj.2023.07.006_b0230","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/jre.12925","article-title":"Influence of anti-rheumatic agents on the periodontal condition of patients with rheumatoid arthritis and periodontitis: A systematic review and meta-analysis","volume":"56","author":"Zhang","year":"2021","journal-title":"J. Periodont. Res."}],"container-title":["The Saudi Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1013905223001190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1013905223001190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:29:57Z","timestamp":1736184597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1013905223001190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1013905223001190"],"URL":"https:\/\/doi.org\/10.1016\/j.sdentj.2023.07.006","relation":{},"ISSN":["1013-9052"],"issn-type":[{"value":"1013-9052","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of anti-TNF-a biological therapy with periodontal conditions and osteonecrosis in autoimmune patients: A systematic review","name":"articletitle","label":"Article Title"},{"value":"The Saudi Dental Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sdentj.2023.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}